Achilles Therapeutics (ACHL) Q4 2022 Earnings

Mar 7Confirmed
May 2022
Aug 2022
Nov 2022
Q4 2022
-0.61
-0.51
-0.42
-0.32

Details

Expected EPS
-0.41
Actual EPS
-0.61
Surprise EPS
-0.2
Surprise Percent
-48.78%

Description

⁨Achilles Therapeutics⁩ (⁦ACHL⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q4 2022⁩.

0 Comments

Share your thoughts